ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,498,032,000 | -83.2% | 79,429 | -89.5% | 0.00% | -83.3% |
| Q2 2019 | $8,908,914,000 | -11.5% | 756,917 | +2.7% | 0.01% | -14.3% |
| Q1 2019 | $10,062,848,000 | +32.5% | 737,205 | -0.5% | 0.01% | 0.0% |
| Q4 2018 | $7,592,862,000 | -45.3% | 740,767 | -11.2% | 0.01% | -30.0% |
| Q3 2018 | $13,887,032,000 | -4.0% | 834,056 | -8.9% | 0.01% | -9.1% |
| Q2 2018 | $14,469,372,000 | +18.4% | 915,783 | -4.8% | 0.01% | +10.0% |
| Q1 2018 | $12,222,860,000 | +5234.6% | 962,430 | +4709.5% | 0.01% | – |
| Q4 2017 | $229,126,000 | -6.5% | 20,011 | 0.0% | 0.00% | – |
| Q3 2017 | $245,135,000 | +92.7% | 20,011 | +80.1% | 0.00% | – |
| Q2 2017 | $127,221,000 | -45.0% | 11,111 | 0.0% | 0.00% | – |
| Q1 2017 | $231,109,000 | +99947.2% | 11,111 | 0.0% | 0.00% | – |
| Q4 2016 | $231,000 | -65.2% | 11,111 | -45.1% | 0.00% | -100.0% |
| Q3 2016 | $664,000 | +67.7% | 20,253 | +27.8% | 0.00% | – |
| Q2 2016 | $396,000 | +38.0% | 15,853 | +82.2% | 0.00% | – |
| Q4 2015 | $287,000 | +0.7% | 8,700 | 0.0% | 0.00% | – |
| Q3 2015 | $285,000 | -36.0% | 8,700 | +3.6% | 0.00% | – |
| Q2 2015 | $445,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |